RPRX
Royalty Pharma Plc
NASDAQ: RPRX · HEALTHCARE · BIOTECHNOLOGY
$50.09
+1.21% today
Updated 2026-04-30
Market cap
$29.37B
P/E ratio
27.83
P/S ratio
12.35x
EPS (TTM)
$1.78
Dividend yield
1.77%
52W range
$31 – $50
Volume
3.2M
Royalty Pharma Plc (RPRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | — | — | — | — | $-29.33M | $-25.33M | $-15.58M | $1.42B | $1.62B | $1.67B | $2.03B | $2.02B | $2.14B | $2.99B | $2.77B | $2.49B |
| Capital expenditures | $64000.00 | $6000.00 | $4000.00 | $0.00 | $7000.00 | $15000.00 | $30000.00 | $63000.00 | $0.00 | $0.00 | $0.00 | $2.29B | $269.59M | $1.72B | $2.20B | $523000.00 | $2.04B | $2.12B | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | $43000.00 | $24000.00 | $5000.00 | $33.27M | $33.27M | $23.92M | $23.06M | $23.00M | $5.67M | $20.50M | $0.00 | $3.85M |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $5.43M | $2.44M | $2.17M | $2.36M | $2.34M | $289.89M |
| Free cash flow | — | — | — | — | — | — | — | — | $-29.33M | $-25.33M | $-15.58M | $-872.39M | $1.35B | $-54.05M | $-162.37M | $2.02B | $102.83M | $872.28M | $2.77B | $2.49B |
| Investing cash flow | — | — | $23.55M | — | — | — | — | — | — | — | — | $-1.59B | $303.42M | $-2.15B | $-2.76B | $-1.87B | $-1.03B | $-2.07B | $-2.68B | $-1.61B |
| Financing cash flow | $241000.00 | $33.09M | $15.88M | $5.00M | $6.39M | $11.71M | $33.75M | $76.95M | $147000.00 | $102000.00 | $2.88M | $-123.25M | $-1.38B | $-1.19B | $1.49B | $385.11M | $-944.86M | $-2.15B | $361.14M | $-1.19B |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $735.17M | $814.36M | $739.28M | $397.00M | $285.18M | $333.32M | $358.33M | $376.46M | $378.25M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $762.48M | $532.37M | $169.70M | — | — | — |